Biotech

All Articles

GSK goes down ph. 2 HPV vaccination over shortage of best-in-class prospective

.GSK has junked a period 2 individual papillomavirus (HPV) vaccine coming from its own pipe after de...

OS Therapies refiles $6M IPO to money HER2 drug, preclinical ADCs

.Operating system Therapies will definitely detail on the NYSE American stock swap this morning via ...

ALX's fizzling CD47 action fee sends inventory spiraling down

.ALX Oncology's period 2 stomach cancer cells reaction price has weakened. After observing its CD47 ...

Ionis axes eye condition coming from intendeds of Roche-partnered prospect after information disappoint

.An Additional of Ionis Pharmaceuticals' key midphase readouts has disappointed expectations, urging...

Biogen's CEO stated no unsafe sell 2023. He prepares to become strong

.While Biogen's pharma peers are actually seeking for late-stage assets with little threat, CEO Chri...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Biography has been a biotech in search of a pipeline after it ditched its own lead assets ov...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned rights to an early Alzheimer's condition plan to Denali Therapeutics, going out...

Takeda taps brand-new mind of US oncology service-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings a...

Vertex, beaten by AATD once more, loses 2 resources on dispose of pile

.Tip's try to handle an unusual genetic illness has hit an additional setback. The biotech threw pai...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter profits record wasn't short of big news. The company welcomed a triad ...